Effects of cyclosporine on cytokines and cytokine receptors in psoriasis. (Record no. 7489834)

MARC details
000 -LEADER
fixed length control field 01552 a2200469 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513030107.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199601s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0190-9622
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/0190-9622(95)90285-6
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Prens, E P
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19960102
245 00 - TITLE STATEMENT
Title Effects of cyclosporine on cytokines and cytokine receptors in psoriasis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Journal of the American Academy of Dermatology
Date of publication, distribution, etc. Dec 1995
300 ## - PHYSICAL DESCRIPTION
Extent 947-53 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Comparative Study; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Administration, Oral
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biopsy, Needle
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cells, Cultured
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cyclosporine
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cytokines
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Flow Cytometry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunohistochemistry
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Inflammation Mediators
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Receptors, Cytokine
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Skin
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Statistics, Nonparametric
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Time Factors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name van Joost, T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hegmans, J P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name t Hooft-Benne, K
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ysselmuiden, O E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Benner, R
773 0# - HOST ITEM ENTRY
Title Journal of the American Academy of Dermatology
Related parts vol. 33
-- no. 6
-- p. 947-53
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/0190-9622(95)90285-6">https://doi.org/10.1016/0190-9622(95)90285-6</a>
Public note Available from publisher's website

No items available.